AEGiS-AP: Profits From AIDS Drug Help Samoans Associated PressImportant note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu




DonateNow



Profits From AIDS Drug Help Samoans

Associated Press - Friday December 14, 2001
David Briscoe, Associated Press Writer


HONOLULU (AP) - The families of two Samoan women who passed on knowledge of a tree's healing powers will share in profits from any AIDS drug developed from the rainforest plant.

In an agreement announced Thursday, the nonprofit AIDS ReSearch Alliance promised to give the government of Samoa and the healers 20 percent of any net profits from an experimental anti-HIV compound called prostratin.

Scientists hope to begin the first clinical trials on humans within a year. The drug, if successful, could earn millions of dollars a year for the Samoans, said Irl Barefield, executive director of ReSearch Alliance, which is licensed to research the drug by the National Cancer Institute.

The federal National Institutes of Health would get 5 percent of any profits. All other profits would go toward AIDS research, he said.

"It could be Samoa's gift to the world," said Dr. Paul Cox, who first brought the herbal compound out of a small Samoan village nearly a decade ago and was rebuffed by pharmaceutical companies that he tried to interest in researching it.

Cox now heads the National Tropical Botanical Gardens in Hawaii and Florida, set up by Congress to conserve tropical plant diversity.

"These healers were heirs to thousands of years of knowledge," Cox said by phone from an AIDS forum in Los Angeles. "They were bright people. Talking to them about the plants was like talking to another Ph.D."

The medicine women used the mamala tree to treat hepatitis. The plant's bark and wood contain prostratin, an experimental phorbol ester that inhibits HIV infection, according to an abstract in Blood, the journal of the American Hematology Society.

The drug works by triggering dormant HIV cells, which can lie undetected for decades, to spring back where they can be attacked by other anti-AIDS drugs, Barefield said. Besides exposing the HIV for destruction, he said, the drug seems to prevent the AIDS virus from entering healthy cells.

The tree's scientific name is Homalanthus nutans. - On the Net: AIDS ReSearch Alliance: http://www.aidsresearch.org National Botanical Tropical Garden: http://www.ntbg.org Blood journal: http://www.bloodjournal.org
011214
AP011215


Copyright © 2001 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .